Aims-To compare the quality of outpatient anticoagulant control before and after the transfer of dosing responsibility to designated trained pharmacists from rotating junior medical staff. Methods-All International Normalised Ratio (INR) values for an eight month period either side of the staff changeover were assessed for precision of therapeutic control according to described standards. Allowing for patient associated effects, observed and expected frequencies of "successful" control for the two staff groups were compared under the hypothesis ofno association. Results-INR results (n = 2219) for 382 patients were analysed. For patients in stable therapeutic control, there was no significant difference in performance between the two staff groups. Patients with an INR result "out" of control limits were more likely to be returned "in" to control at their next visit by the pharmacists than by the doctors. Conclusions-The quality ofanticoagulant control in outpatient clinics benefits from dedicated trained staffusing standard protocols. ( Clin Pathol 1995;48:545-547) 
Oral anticoagulants are a standard therapy in the treatment of thromboembolic disease. Indications for their use have expanded and increasing numbers of patients now take these drugs.' Many require lifelong treatment and are regularly monitored in hospital outpatient clinics. The optimal level of anticoagulation depends upon the underlying condition and guidelines have been proposed by the British Society for Haematology.2 The control of anticoagulation is influenced by many factors including intercurrent disease and drug therapy, and knowledge of these aids accurate control. 3 Institutions vary in the type of staff who undertake dosage control in anticoagulant clinics. Examples include consultant haematologists, clinical assistant medical staff, rotating junior medical staff, and pharmacists. Com The quality ofanticoagulant control was analysed using audit standards developed for the anticoagulant service at Sunderland Hospitals.7 The local standards define an acceptable precision of control as compliance with the prescribed INR range plus or minus 0 5. INR values recorded in this way were analysed by means of a database facility at the University of Sunderland (dBase IV, Ashton Tate).
STATISTICAL ANALYSIS
To avoid the need for a more complex statistical model, involving assumptions about the forms of probability distributions, the observations were classified as belonging to one or other of the two states "in" or "out" of the prescribed range plus or minus 05. This permitted a nonparametric comparison of the proportions "in" achieved by the physicians and pharmacists. It seemed likely that the probability of successful control-that is, achieving the state "in"5, would vary between patients and also according to each patient's recent history. Individual patients were observed several times during the course of the study. Some patients were seen only by the physicians, some only by the pharmacists and some were seen before and after the change in clinic management. There was no randomisation or matching of patients between physicians and pharmacists. For these reasons, it was necessary to allow for possible within-patient dependence in the data. As an initial analysis, McNemar's test8 was used to compare results between the last two physician visits and the first two pharmacist visits, for those patients where these data were available. This avoids the possibility of dominance of the results by unstable patients who might contribute more data and also to reduce any time effects. This test was supplemented by an analysis of the whole data set. With such a large number of patients and a small number of observations per patient, the fitting of explicit patient effects was rejected in favour ofa Markov chain model. In this model the probability of successful control on one occasion depends on the state of that patient at the previous occasion but, given that previous state, there is no further de- Haematologyl' has highlighted a lack of precision in therapeutic control in anticoagulated patients, a lack ofstandardisation in therapeutic standards and has recommended an increase in educational input by consultant haematologists. Other authors have criticised the quality of anticoagulant control in hospital outpatient clinics."`' Junior doctor involvement in these clinics has been questioned through lack of continuity, training, knowledge, and commitment due to more pressing duties. '4 A similar situation existed in the United States where pharmnacist operated clinics have reported improved control of anticoagulant therapy.516 These authors suggested that their results were achieved through continuity of care. The turnover of clinic personnel in their pharmacist clinics was low when contrasted with the previous situation of high junior medical staff turnover. The pharmacist clinics were operated within established guidelines to standardise the general aspects of patient management and each pharmacist underwent specialist training and assessment before taking responsibility for patient care within the clinic. This training included a grounding in the pharmacokinetic principles of warfarin dosing. In this environment direct patient contact and a patient-provider relationship was established and improved patient awareness of anticoagulant therapy through counselling and education was encouraged.
When embarking on a service development, it is important to ensure that patient care does not deteriorate through the change. Maintenance of good patient care in the clinic in Sunderland has been enabled by close cooperation between disciplines and the use of protocols and recognised standards. This has created an environment in which pharmacists' skills in dosage titration, patient counselling and management of adverse drug reactions could best be utilised. The relatively new tool ofprofessional audit has helped clinic personnel to focus on the aims of improved anticoagulant control and reduced thromboembolic and haemorrhagic complications. '7 The results of the comparison of control reported in this study demonstrate the benefits of dedicated staffing, specialised training, standard protocols, and defined treatment objectives for each patient. With the increasing pressure on health authorities to reduce junior doctors' hours and the increasing number of patients requiring anticoagulation, it would seem that pharmacist managed clinics offer a suitable alternative for managing the care of patients on anticoagulant drugs. The system used in Sunderland appears to overcome some of the problems described in the recent BCSH audit of anticoagulant treatment and we would advocate its use in other clinics.
